The serial chromatographic separation of chloroform and n-butanol fractions of Ammannia multiflora resulted in the isolation and characterization of 4hydroxy-α-tetralone (1) and 3,3'-(2R,5R)-tetrahydrofuran-2,5-diyldiphenol (ammaniol, 2). Compound 1 was chemically modified into six semi-synthetic acyl and aryl derivatives (1A -1F). The isolated compounds 1 and 2 along with semi-synthetic derivatives 1A -1F were evaluated for in vitro antihyperglycemic activity employing 2-deoxyglucose uptake by L-6 rat muscle cell lines. The results indicated that both the isolates, as well as derivatives (1A -1F), have the property to stimulate glucose uptake. Ammaniol (2) increased glucose uptake significantly (64.8%), while one of the aryl derivatives of 1, 4-O-(3,4,5trimethoxybenzoyl)-α-tetralone (1D), showed potent antihyperglycemic activity and increased glucose uptake by 94.6%, even more than rosiglitazone (88.8%). Further, since 1D possesses better antihyperglycemic activity than rosiglitazone (standard), this might be a new safer antidiabetic drug of herbal origin.
Diabetes mellitus is one of the most common endocrine disorders and is a major global health problem affecting more than 5% of the world's population [1] . Diabetes can be classified clinically as insulin-dependent diabetes mellitus (type-1 diabetes) and noninsulin-dependent diabetes mellitus (type-2 diabetes). Both forms (type-1 and type-2) are associated with major long-term complications, including cardiomyopathy, angiopathy, neuropathy, retinopathy, nephropathy and digestive insufficiencies [2] . According to the World Health Organization (WHO), at present an estimated 346 million people worldwide have diabetes and in 2004, nearly 3.4 million people died from consequences of high blood sugar [3] . Traditional medicines, mainly derived from plant sources, have been prescribed widely for the treatment of diabetes mellitus because of their effectiveness, less side effects and relatively low cost [4] .
Plants of the genus Ammannia (Family-Lythraceae) are commonly called 'Red stems' and are nearly cosmopolitan in distribution, including India. One species, A. baccifera, is frequently used in traditional Chinese medicine to cure spinal disease [5] , urethritis [6] , human female infertility and gastroenteropathy [7] . A. baccifera is also reported to possess antipyretic, antidiuretic, antimicrobial, anticancer and antisteroidal properties [7] . A. multiflora (Roxb.) is an erect annual herb with numerous four angled branches growing in marshy places along the banks of rivers and rivulets and cultivated paddy fields [7] . In Tanzania the juice of fresh leaves of A. multiflora is used to treat sight problems in human adults, caused by filaria [8] . In continuation of our efforts towards drug discovery from A. multiflora [7, 9] , the current study was aimed at its antihyperglycemic potential. Further, it was found that the isolated compound 1 has already been reported to possess significant antituberculosis, anti-leishmanial [7] and PTP1B inhibition [10] activities. We have prepared derivatives of 4-hydroxy-α-tetralone (1) to study their structure activity relationship (SAR). To the best of our knowledge, the antihyperglycemic potential has not been evaluated of the isolated compounds 1and 2, and the acyl analogs of Further, compound 1 has been reported as a potent inhibitor of PTP1B [10] , which plays a role in the dephosphorylation of the insulin receptors and hence in the insulin resistance associated with diabetes and obesity [11] . Therefore, the use of specific PTP1B inhibitors may enhance insulin action and represents a novel strategy for the treatment of type-2 diabetes [12] . The results showed that compound 1 increased glucose uptake by 12.2% while compound 2 increased glucose uptake by 64.8%. In an earlier study, compound 1 and 4-hydroxy-α-tetralone-4-O-β-D-[6′-O-(3″,4″,5″ trihydroxybenzoyl) glucopyranoside were evaluated for their PTP1B inhibition potential and it was found that 1 (lipophilic) was a more potent PTP1B inhibitor than the latter (hydrophilic) [10] . Hence, from this report, it may be concluded that the increased lipophilicity of the tetralone moiety enhances PTP1B inhibiting activity that ultimately may enhance its antihyperglycemic potential. The results of the in vitro antihyperglycemic activity evaluation of compounds 1, 2 and six semi-synthetic derivatives 1A-1F in terms of 2-deoxyglucose uptake by L-6 muscle cell lines have been expressed as fold induction in glucose uptake with respect to unstimulated cells (Figure 1 ). Careful analysis of the results reveals that the antihyperglycemic potential of all the semi-synthetic derivatives (1A -1F) is more than that of their parent compound (1), justifying our assumption. The increase in glucose uptake is 27.6, 27.5, 28.0, 94.6, 32.2 and 36.1% for 1A, 1B, 1C, 1D, 1E and 1F, respectively. Since 1D (4-O-(3,4,5trimethoxybenzoyl)-α-tetralone) showed more than a threefold greater increase in glucose uptake than 1A (4-O-m-anisoyl-αtetralone), it can also be concluded that the three methoxy groups at successive positions of the benzoyl moiety may be responsible for the enhanced glucose uptake by 1D. Further, as 1D increased the glucose uptake, even more than rosiglitazone, a commonly used drug for diabetes, after a detailed study of all the related aspects, in future this might be a better, new and safe antidiabetic drug of herbal origin.
In conclusion, the present investigation led to the isolation and characterization of novel antihyperglycemic leads, 4-hydroxy-αtetralone (1) and ammaniol (2) from A. multiflora. The SAR study revealed that substitution by lipophilic groups of the 4-hydroxyl group of compound 1 enhances the glucose uptake by L6 skeletal muscle cells in vitro. Further, since compound 2 and one of the semi-synthetic derivatives, 1D, are potentially antihyperglycemic, it is suggested that optimization of these leads for various aspects like their mode of action and in vivo behaviour, including their effect in secondary complications associated with diabetes is required for the future development of them as antidiabetic drugs.
Experimental
The samples of A. multiflora were collected from the Lucknow district of Uttar Pradesh, India in October, 2010 and identified by Dr D. C. Saini, Scientist, Birbal Shahni Institute of Palaeobotany (BSIP), Lucknow, and Dr S. C. Singh, Taxonomy and Pharmacognosy Division, Central Institute of Medicinal & Aromatic Plants (CIMAP), Lucknow, India. A voucher specimen No. 9455 is available in the herbarium of CIMAP. Extraction of plant material, isolation of compounds (1 and 2) from extract fractions, chemical derivatization of 1 into 6 acyl and aryl derivatives (1A-1F) and their characterization was carried out by an earlier described method [7] . In vitro antihyperglycemic assay: This was carried out in L6 rat skeletal muscle myotubes, and the determination of 2-deoxyglucose (2-DG) uptake was performed by following an earlier described method [13] .
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Statistical analysis: Values are given as mean ± SE. Analysis of statistical significance of differences in measurements between samples was done by one-way ANOVA with Dunnets post hoc test (Graph Pad Prism version 3). p<0.05 was considered statistically significant.
